Timothy Plan US Large/Mid Cap Core ETF (TPLC) Chart & Stock Price History $43.27 +0.06 (+0.14%) (As of 09:27 AM ET) Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOwnershipRatings Timothy Plan US Large/Mid Cap Core ETF Stock Price Performance5 Day Performance+0.21%1 Month Performance-1.75%3 Month Performance+8.23%6 Month Performance+7.46%Year-To-Date Performance+13.24%1 Year Performance+25.64% Receive TPLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Timothy Plan US Large/Mid Cap Core ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad TradingTipsTop 10 AI Stocks to Buy NowAre you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.Download our free report today TPLC Stock Chart for Tuesday, November, 5, 2024 TPLC Chart by TradingView Timothy Plan US Large/Mid Cap Core ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$43.08$43.21+0.31%$43.37$43.1612,243 shs$241.98 million11/01/2024$43.18$43.08-0.23%$43.45$43.08101,653 shs$241.25 million10/31/2024$43.61$43.18-0.99%$43.50$43.177,856 shs$241.81 million10/30/2024$43.68$43.61-0.16%$43.85$43.5915,376 shs$244.22 million10/29/2024$43.75$43.68-0.16%$43.78$43.6110,950 shs$244.61 million10/28/2024$43.56$43.75+0.44%$43.83$43.6410,945 shs$245 million Get the Latest News and Ratings for TPLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Timothy Plan US Large/Mid Cap Core ETF and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$43.83$43.56-0.62%$43.99$43.5213,135 shs$243.94 million10/24/2024$43.97$43.83-0.32%$44.00$43.8015,141 shs$245.45 million10/23/2024$44.00$43.97-0.07%$43.98$43.6414,853 shs$246.23 million10/22/2024$44.35$44.00-0.79%$44.09$43.9117,603 shs$246.40 million10/21/2024$44.73$44.35-0.85%$44.74$44.3012,251 shs$248.36 million10/18/2024$44.59$44.73+0.31%$44.76$44.5726,709 shs$250.49 million10/17/2024$44.58$44.59+0.02%$44.69$44.5114,835 shs$249.70 million10/16/2024$44.40$44.58+0.41%$44.62$44.3413,470 shs$249.65 million10/15/2024$44.64$44.40-0.54%$44.85$44.3311,439 shs$248.64 million10/14/2024$44.38$44.64+0.59%$44.71$44.467,050 shs$249.98 million10/11/2024$43.93$44.38+1.02%$44.40$43.977,085 shs$248.53 million10/10/2024$44.12$43.93-0.43%$43.99$43.8012,288 shs$246.01 million10/09/2024$43.75$44.12+0.85%$44.13$43.7812,415 shs$247.07 million10/08/2024$43.59$43.75+0.37%$43.82$43.6212,600 shs$245 million10/07/2024$44.04$43.59-1.02%$43.90$43.5410,887 shs$244.10 million10/04/2024$43.74$44.04+0.69%$44.14$43.837,810 shs$246.62 million10/03/2024$43.85$43.74-0.25%$43.86$43.5822,848 shs$244.94 million10/02/2024$43.77$43.85+0.18%$43.93$43.7368,068 shs$245.56 million10/01/2024$43.99$43.77-0.50%$43.99$43.5518,926 shs$245.11 million09/30/2024$43.87$43.99+0.27%$44.00$43.5898,685 shs$246.34 million09/27/2024$43.79$43.87+0.18%$44.06$43.7610,973 shs$245.67 million09/26/2024$43.43$43.79+0.83%$43.79$43.618,147 shs$245.22 million09/25/2024$43.70$43.43-0.62%$43.78$43.429,994 shs$243.21 million09/24/2024$43.71$43.70-0.02%$43.79$43.675,523 shs$244.72 million09/23/2024$43.39$43.71+0.74%$43.73$43.548,296 shs$244.78 million09/20/2024$43.55$43.39-0.37%$43.51$43.248,183 shs$242.98 million09/19/2024$43.04$43.55+1.18%$43.68$43.4117,541 shs$243.88 million09/18/2024$43.14$43.04-0.23%$43.48$43.037,236 shs$241.02 million09/17/2024$43.04$43.14+0.23%$43.37$43.0411,006 shs$241.58 million09/16/2024$42.76$43.04+0.65%$43.10$42.9027,693 shs$241.02 million09/13/2024$42.29$42.76+1.11%$42.79$42.509,482 shs$239.46 million09/12/2024$42.05$42.29+0.57%$42.32$41.9010,885 shs$236.82 million09/11/2024$42.02$42.05+0.07%$42.10$41.1518,538 shs$235.48 million09/10/2024$41.94$42.02+0.19%$42.02$41.815,850 shs$235.31 millionNASDAQ small cap that could be gearing up for a massive short squeeze. (Ad)A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!See how this NASDAQ Bio-tech is offering viable solutions09/09/2024$41.56$41.94+0.91%$42.05$41.8211,246 shs$234.86 million09/06/2024$42.00$41.56-1.05%$42.12$41.567,500 shs$232.74 million09/05/2024$42.35$42.00-0.83%$42.37$41.8915,748 shs$235.20 million09/04/2024$42.32$42.35+0.07%$42.48$42.2015,145 shs$237.16 million09/03/2024$43.19$42.32-2.01%$42.99$42.2916,423 shs$236.99 million09/02/2024$43.19$43.19$43.19$42.7433,900 shs$241.86 million08/30/2024$42.83$43.19+0.85%$43.19$42.7433,940 shs$241.86 million08/29/2024$42.66$42.83+0.39%$43.10$42.8326,501 shs$239.82 million08/28/2024$42.83$42.66-0.40%$42.88$42.5223,228 shs$238.90 million08/27/2024$42.83$42.83$42.85$42.7311,544 shs$239.85 million08/26/2024$42.91$42.83-0.18%$43.16$42.8114,212 shs$239.85 million08/23/2024$42.38$42.91+1.25%$42.92$42.668,985 shs$240.30 million08/22/2024$42.53$42.38-0.35%$42.68$42.388,777 shs$237.34 million08/21/2024$42.18$42.53+0.83%$42.56$42.3484,041 shs$238.17 million08/20/2024$42.40$42.18-0.52%$42.45$42.1217,327 shs$236.21 million08/19/2024$42.07$42.40+0.78%$42.41$42.1111,827 shs$237.44 million08/16/2024$42.00$42.07+0.17%$42.11$41.929,476 shs$235.59 million08/15/2024$41.52$42.00+1.16%$42.08$41.879,771 shs$235.20 million08/14/2024$41.38$41.52+0.34%$41.53$41.3910,462 shs$232.51 million08/13/2024$40.90$41.38+1.17%$41.38$41.018,670 shs$231.73 million08/12/2024$41.06$40.90-0.39%$41.16$40.8916,324 shs$229.04 million08/09/2024$40.99$41.06+0.17%$41.12$40.7111,131 shs$229.94 million08/08/2024$40.34$40.99+1.61%$41.04$40.4019,561 shs$229.54 million08/07/2024$40.44$40.34-0.25%$40.99$40.29117,830 shs$225.90 million08/06/2024$39.98$40.44+1.15%$40.94$40.16283,068 shs$226.46 million08/05/2024$40.92$39.98-2.30%$40.23$39.7813,735 shs$223.89 million Related Companies GGUS Stock Price Chart RUNN Stock Price Chart POWA Stock Price Chart SMRI Stock Price Chart ROE Stock Price Chart TOGA Stock Price Chart EFAA Stock Price Chart UPGD Stock Price Chart XOVR Stock Price Chart CGCV Stock Price Chart Receive TPLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Timothy Plan US Large/Mid Cap Core ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:TPLC) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Timothy Plan US Large/Mid Cap Core ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Timothy Plan US Large/Mid Cap Core ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.